![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 31, 21695-21700, July 30, 1999
From the Hydroperoxide-induced tyrosyl radicals are
putative intermediates in cyclooxygenase catalysis by prostaglandin H
synthase (PGHS)-1 and -2. Rapid-freeze EPR and stopped-flow were used
to characterize tyrosyl radical kinetics in PGHS-1 and -2 reacted with
ethyl hydrogen peroxide. In PGHS-1, a wide doublet tyrosyl radical
(34-35 G) was formed by 4 ms, followed by transition to a wide singlet
(33-34 G); changes in total radical intensity paralleled those of
Intermediate II absorbance during both formation and decay phases. In
PGHS-2, some wide doublet (30 G) was present at early time points, but
transition to wide singlet (29 G) was complete by 50 ms. In contrast to
PGHS-1, only the formation kinetics of the PGHS-2 tyrosyl radical
matched the Intermediate II absorbance kinetics. Indomethacin-treated
PGHS-1 and nimesulide-treated PGHS-2 rapidly formed narrow singlet EPR
(25-26 G in PGHS-1; 21 G in PGHS-2), and the same line shapes
persisted throughout the reactions. Radical intensity paralleled
Intermediate II absorbance throughout the indomethacin-treated PGHS-1
reaction. For nimesulide-treated PGHS-2, radical formed in concert with
Intermediate II, but later persisted while Intermediate II relaxed.
These results substantiate the kinetic competence of a tyrosyl radical
as the catalytic intermediate for both PGHS isoforms and also indicate
that the heme redox state becomes uncoupled from the tyrosyl radical in
PGHS-2.
Prostaglandin H synthase
(PGHS)1 catalyzes the first
committed step in the biosynthesis of prostanoids. There are two
isoforms of PGHS, with the constitutive form (PGHS-1) ascribed
housekeeping functions and the inducible form (PGHS-2) associated with
cytokine-mediated pathophysiological events (1, 2). Although the
isoforms share only 60% sequence identity, their overall
three-dimensional structures are very similar, especially in the
catalytic sites (3-5). Both isoforms exhibit two enzymatic activities:
a cyclooxygenase activity, which converts arachidonic acid to
prostaglandin G2, and a peroxidase activity, which
transforms prostaglandin G2 to prostaglandin
H2. Several oxidized reaction intermediates have been
identified (6-9). As indicated in Scheme 1, PGHS first interacts with
a peroxide substrate, such as prostaglandin G2, to generate Intermediate I, equivalent to Compound I of horseradish peroxidase. Intermediate I then converts to Intermediate II, equivalent to complex
ES of cytochrome c peroxidase, through an intramolecular electron transfer from a tyrosine residue to the oxidized porphyrin. The transient tyrosyl radical in Intermediate II in each PGHS isoform
is capable of oxidizing arachidonic acid to generate an arachidonic
acid radical and initiate cyclooxygenase catalysis (10, 11).
Crystallographic data revealed that the presumed site of the tyrosyl
radical, Tyr-385 in PGHS-1 (Tyr-371 in PGHS-2), is located between the
heme and arachidonate binding sites, well positioned to couple the two
enzyme activities (3-5), as proposed in the original branched-chain
mechanism (7, 8) (Scheme 1).
Although the chemical competence of the tyrosyl radical for
cyclooxygenase catalysis has been convincingly demonstrated by single-turnover experiments (10, 11), the kinetic competence of the
tyrosyl radical had been examined only with manual mixing techniques
(13). Thus, the relationship between tyrosyl radical kinetics and those
of the rapid changes in the heme redox state during PGHS peroxidase
reactions remained unresolved. The redox linkage between the heme
center and the tyrosyl radical needs to be defined to determine the
coupling efficiency between the two enzyme activities.
Several types of tyrosyl radical EPR spectra have been observed in the
PGHS isozymes (Refs. 7, 12-16 and Table
I). A 33-35-G wide doublet (WD1) and wide singlet (WS1) are observed
when PGHS-1 is manually mixed with various hydroperoxides (12). On the
other hand, only a 29-G wide singlet (WS2) is found in PGHS-2 for
similar manually mixed peroxidase reactions (16, 24). It was of
interest to know whether the lack of observable WD in PGHS-2 was the
result of a fundamentally different tyrosyl radical structure in this isoform or of a more rapid transition to a wide singlet. The peroxidase reaction in PGHS-1 treated with cyclooxygenase inhibitors such as
aspirin, indomethacin, and flurbiprofen or with the mutation of Tyr-385
to phenylalanine resulted in the formation of a 25-26-G narrow singlet
(NS1a) (12, 17, 18). A similar 21-G narrow singlet (NS2a) was observed
for PGHS-2 treated with the cyclooxygenase inhibitor nimesulide or with
the mutation of Tyr-371 (11, 16). These observations of a perturbed
tyrosyl radical EPR in PGHS-1 and -2 with impaired cyclooxygenase
activity were from manually mixed samples. It remained important to
determine whether other radicals were generated earlier in the rapid
reactions with peroxide.
Rapid Kinetics of Tyrosyl Radical Formation and Heme Redox
State Changes in Prostaglandin H Synthase-1 and -2*
§,
,
,
,
, and
Division of Hematology, Department of
Internal Medicine, University of Texas Health Science Center,
Houston, Texas 77030, the ¶ Department of Biochemistry and Cell
Biology, Rice University, Houston, Texas 77005, and the
Arthritis Research Department, Novartis Pharmaceuticals, Summit,
New Jersey 07901
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (19K):
[in a new window]
Scheme 1.
Branched-chain radical mechanism of PGHS.
AA, arachidonic acid; PGG2,
prostaglandin G2; PGH2,
prostaglandin H2; ROOH and ROH,
hydroperoxide and corrresponding alcohol.
Tyrosyl radical EPR species in PGHS-1 and -2
We have used rapid-freeze EPR to measure the tyrosyl radical kinetics
during reaction of PGHS-1 and -2 with EtOOH, both with and without
pretreatment of the enzymes with cyclooxygenase inhibitors. Parallel
stopped-flow measurements were done to determine the kinetics of
Intermediate I and II formation. The results indicate that very rapid
formation of WD species coincides with formation of Intermediate II in
both PGHS-1 and -2, consistent with the proposed mechanism (Ref. 7 and
Scheme 1), and the formation of the narrow singlet EPR coincides with
Intermediate II formation in the isozymes treated with cyclooxygenase inhibitors.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Phenol, indomethacin, flurbiprofen, nimesulide, and hemin were
purchased from Sigma. EtOOH was purchased as a 5% aqueous solution from Polysciences Inc. (Warrington, PA) or from Accurate Chemical and
Scientific Corp. (Westbury, NY) as a 10% solution. EtOOH
concentrations were determined from the absorbance at 230 nm using an
extinction coefficient of 43 M
1
cm
1. Tween 20 was purchased from Pierce.
PGHS-1 was prepared as the apoenzyme from ram seminal vesicles, with 5 mM glutathione included in the isoelectric focusing step
(9, 20). Recombinant human PGHS-2 was expressed in a baculovirus system
using Sf9 or High Five (Invitrogen) insect cells and purified as
described previously (21). PGHS holoenzymes were formed by adding
excess heme to the apoenzyme followed by treatment with DE52 cellulose
(Whatman) and gel filtration on a Bio-Rad 10-DG column (for PGHS-1) or
gel filtration alone (for PGHS-2). A minimal amount of phenol (50 µM) was added to PGHS-2 during reconstitution to avoid
loss of activity. The concentration of PGHS holoenzyme was based on the
absorbance at 411 nm for PGHS-1 and at 408 nm for PGHS-2 (165 mM
1 cm
1).
The cyclooxygenase specific activity, assayed polarographically at 30 °C (20), was 80-120 µmol of O2/min/mg for PGHS-1 and 10-30 µmol of O2/min/mg for PGHS-2.
Optical stopped-flow kinetic measurements were conducted using a Bio-SEQUENTIAL DX-18MV stopped-flow instrument (Applied Photophysics, Leatherhead, UK). Wavelength pairs of 428 and 524 nm (isosbestic points between resting PGHS-1 and Intermediate I (8, 9)) were used to monitor changes in Intermediate II in PGHS-1. In the case of PGHS-2, the large value of k2 (conversion of Intermediate I to Intermediate II) resulted in a minimal accumulation of Intermediate I, and so there was hardly any observable accumulation of Intermediate I (26). We thus chose to monitor Intermediate II kinetics in PGHS-2 at 406 and 428 nm.
Rapid-freeze experiments were conducted using a System 1000 chemical/freeze quench apparatus with a Model 1019 syringe ram, a Model
715 ram controller, and an 0.008-in nozzle (Update Instrument, Inc.
Madison, WI). A low temperature isopentane bath was used for
pre-chilling the packing assembly containing isopentane and later for
cooling during sample packing via a pressure filtration process
developed recently in our laboratory (19). The bath temperature was
kept at 125-130 K, bringing the temperature of isopentane inside the
funnel to 130-135 K. The temperatures were monitored with a silicon
diode temperature sensor (Lakeshore model 200 monitor with a DT-471-PA1
probe). Unless otherwise mentioned, the ram velocity was 2 cm/s in all
rapid-mixing experiments. Single-push mixing was used for reactions of
less than 160 ms; longer reactions used a push-push mixing syringe
program. The dead time of the apparatus, measured with myoglobin-azide
reactions, is 4-5 ms (19). EPR spectra of samples collected from
rapid-freeze experiments were recorded with a Varian E-6 spectrometer.
The EPR conditions were as follows: modulation amplitude, 3.2 G; time
constant, 1 s; power 1 mW; and temperature, 96 K. Radical
concentrations were determined by double integration of the EPR signal
using a copper standard (12) and a packing correction factor of 0.45 determined earlier for this system (19).
| |
RESULTS |
|---|
|
|
|---|
Kinetics of PGHS-1 Tyrosyl Radicals--
To observe the earliest
possible events in tyrosyl radical formation, we reacted PGHS-1 with
two equivalents of EtOOH at 0 °C and freeze-trapped the sample at
various reaction times. The sample trapped at 4 ms showed a typical
wide-doublet tyrosyl radical (WD1) with a peak-to-trough width of 34 G
and a well resolved 19-G center splitting (Fig.
1). A sample trapped after 5 s of reaction still showed a doublet spectrum but with some decay of the
center splitting. Comparison of the freeze-trapped samples with the
wide-doublet EPR predicted from the parameters obtained in electron
nuclear double resonance (ENDOR) measurements2
indicates that the center splitting in
the WD1 EPR had already declined by ~30% at 4 ms (Fig. 1).
|
Increasing the ratio of EtOOH/PGHS-1 to 5 and raising the temperature
permitted observation of a more complete transition from WD1 to a wide
singlet tyrosyl radical (WS1) (Fig. 2,
top). This transition was essentially complete within
50 s. The initial formation of tyrosyl radical was rapid
(k = 16 s
1) and reached a plateau at
~0.6 spin/heme within 300 ms (Fig. 2, bottom). A slow
decay in radical intensity (k = 0.047 s
1) began after about 500 ms (Fig. 2, bottom).
The kinetics of Intermediate II, monitored at
A524, closely tracked those of the tyrosyl
radical. The rate of Intermediate II formation was 24 s
1
(Fig. 2, bottom). These results indicate a tight redox
linkage between the heme center and the tyrosyl radical in PGHS-1. The slight difference in formation rates between tyrosyl radical and Intermediate II probably originates in the different methods used for
their measurement, but it might also imply an additional step occurring
between formation of Intermediate II and tyrosyl radical. Stopped-flow
observations at 428 nm paralleled those at 524 nm in the early phase
but showed a more rapid decay (data not shown), indicating that
additional events, such as self-inactivation, were also detected at
this wavelength (25).
|
Effects of Cyclooxygenase Inhibitors on PGHS-1 Tyrosyl Radical
Kinetics--
The EPR spectra of samples trapped at various times
during reaction of indomethacin-treated PGHS-1 and EtOOH (5 eq) all
showed a 25-26-G narrow singlet (NS1a) with discrete hyperfine
features (Fig. 3, top) just as
was found earlier in manual mixing experiments (12, 17). There was no
indication of initial formation of either WD1 or WS1 signals. Formation
of the NS1a radical was rapid (k = 47 s
1)
and reached a plateau at ~0.35 spin/heme within 200 ms, followed by a
slow relaxation (Fig. 3, bottom). As in the case of PGHS-1 itself, the kinetics of Intermediate II (29 s
1 for the
initial phase) paralleled those of the NS1a radical, indicating that
binding of indomethacin did not disrupt the redox linkage between the
heme and the tyrosyl radical. Separate experiments using flurbiprofen
instead of indomethacin gave very similar results for both the tyrosyl
radical and Intermediate II kinetics (data not shown).
|
Kinetics of PGHS-2 Tyrosyl Radicals--
Substantial formation of
tyrosyl radicals was evident at the earliest stage (5 ms) of reaction
of PGHS-2 with 5 eq of EtOOH (Fig. 4,
top). The EPR spectrum of the initial sample exhibited a
complex, 29-30-G wide signal with a clearly discernible splitting, whereas the spectrum of the sample at 50 ms was essentially a simple
singlet (WS2), indicating a very rapid transition from doublet to
singlet in PGHS-2. Subtraction of 75% of the signal intensity of the
50-ms sample from the 5-ms sample EPR yielded a doublet with a
peak-to-trough width of 30 G (Fig. 4, top), indicating the
presence of a substantial wide doublet tyrosyl radical in the very
early stages of the PGHS-2 peroxidase reaction.
|
The formation of tyrosyl radical in PGHS-2 was rapid (~140
s
1). The radical intensity reached a plateau near 0.8 spin/heme by ~50 ms and remained at this level for at least 100 ms
(Fig. 4). Formation of Intermediate II, monitored by absorbance changes at 406 or 428 nm, was also rapid (~240 s
1). In contrast
to the persistent radical intensity, Intermediate II quickly relaxed
back to the ferric heme (17-19 s
1). This difference in
behavior between the heme center redox state and the tyrosyl radical
was observed for PGHS-2 but not PGHS-1 (compare Figs. 2 and Fig.
4).
The PGHS-2 preparation used above included 50 µM phenol
as a protectant, and therefore the possible effect of phenol on the PGHS-1 tyrosyl radical and Intermediate II kinetics was examined. In
the presence of phenol the rates of tyrosyl radical and Intermediate II
formation (18 and 26 s
1, respectively) were similar to
those for phenol-free PGHS-1 reactions (Figs. 2 and
5). The maximal tyrosyl radical intensity
in the presence of phenol was ~0.4 spin/heme, somewhat less than in
the experiment done without phenol (Figs. 2 and 5). The presence of phenol resulted in a slower transition from WD1 to WS1, evident from
the center inflection present in the EPR even after 330 ms (Fig. 5,
top). This finding contrasts with the almost complete collapse of the center splitting pattern in the phenol-free PGHS-1 reactions (Fig. 2, top). A comparison of the PGHS-1 and -2 results in the presence of phenol indicated that the transition from
wide doublet to wide singlet and the relaxation of Intermediate II were
both slower in PGHS-1 (Figs. 4 and 5).
|
Tyrosyl Radical Kinetics in Nimesulide-treated
PGHS-2--
Reaction of nimesulide-treated PGHS-2 with 5 eq of EtOOH
resulted in rapid formation of both the tyrosyl radical (176 s
1) and Intermediate II (~ 350 s
1 from
A428 observations) (Fig.
6). Intermediate II later decayed at a
rate of 33 s
1 even though the tyrosyl radical intensity
remained relatively constant (Fig. 6, bottom). The divergent
decay kinetics of oxidized heme and tyrosyl radical were thus seen with
both inhibitor-treated and native PGHS-2 (Figs. 4 and 6). The maximal
intensity of the tyrosyl radical achieved in nimesulide-treated PGHS-2,
~0.4 spin/heme, was substantially lower than that found for PGHS-2
itself. EPR of samples collected throughout the reaction showed only
the 21-G narrow singlet (NS2a), with no significant change in line
shape (Fig. 6). There was no sign of earlier formation of either a wide doublet or wide singlet, a situation similar to that with
indomethacin-treated PGHS-1 (Figs. 3 and 6).
|
| |
DISCUSSION |
|---|
|
|
|---|
The rapid formation of WD and WS tyrosyl radicals observed in both PGHS-1 and -2 parallels the formation of the oxyferryl heme species (Intermediate II). This finding is just as predicted by the branched-chain radical mechanism originally proposed by Ruf and colleagues (7, 8). The kinetic competence of the tyrosyl radical for the proposed coupling of the peroxidase and cyclooxygenase activities in both of the PGHS isoforms is thus firmly established.
We previously examined the time-dependent changes of tyrosyl radical concentration and EPR line shape on a time scale of seconds using manual mixing at lower temperatures (-10 to 0 °C) (12, 13, 17). The slower kinetics observed in these earlier experiments probably reflects a previously unsuspected inefficiency in mixing the enzyme and peroxide in the narrow EPR tube by agitation with a nichrome wire loop. Earlier results from single-turnover experiments firmly established the chemical competence of the tyrosyl radical to oxidize arachidonic acid to a fatty acid radical (10, 11, 22, 23). It is clear from the present kinetic results that tyrosyl radicals in both of the PGHS isoforms are formed very rapidly, in concert with heme redox changes, just as expected from the proposed mechanism (Scheme 1). This result provides strong support for the mechanism and indicates that it accurately describes the events leading from the reaction with peroxide to the initiation of cyclooxygenase catalysis in both PGHS-1 and -2.
The present results also make it clear that a wide doublet tyrosyl radical (WD2) species is formed early in the reaction of peroxide with PGHS-2 just as with PGHS-1. The initial wide doublet undergoes a transition to a wide singlet in both isozymes, with a much faster rate for the transition in PGHS-2. Our ENDOR studies2 support earlier reports (14, 15) that the WS1 of PGHS-1 is not a distinct species but is rather a mixture of the WD1 and a narrow-singlet (NS1b) associated with self-inactivated enzyme (13). This singlet is roughly similar to that seen with PGHS inhibited by anti-cyclooxygenase agents (NS1a) but lacks the latter's detailed hyperfine features (13). Conditions that decrease PGHS-1 self-inactivation, such as decreasing the amount of EtOOH (Fig. 1) or including a reducing co-substrate (Fig. 5), significantly slowed the transition from WD to WS, consistent with the assignment of the NS1b signal to a tyrosyl radical in self-inactivated PGHS-1.
The structural interpretation for the WS observed in PGHS-2 (WS2) is
ambiguous despite the general EPR similarities with the WS1 in PGHS-1.
Definitive ENDOR data are not available for any of the PGHS-2 radical
species. The narrower EPR line width of WS2 than of WS1 allows
simulation of WS2 by simply increasing the dihedral angle between the
pz orbital of C1 and the C-H bond at the
carbon, corresponding to a change in coupling constant from 21 to 14 G
for the
proton (16). This interpretation is consistent with WS2
arising from a distinct structural entity. However, it remains possible
that WS2 is a mixture of a wide doublet and a narrow singlet, similar
to WS1 in PGHS-1. ENDOR analysis of WS2 will be needed to decide
between these two alternative structural interpretations and to
understand the basis for the WD
WS transition observed in PGHS-2
(Fig. 4).
The present rapid-freeze EPR measurements did not detect formation of either WD or WS signals, even in the earliest stages of the peroxidase reaction, in either indomethacin-PGHS-1 or nimesulide-PGHS-2 (Figs. 3 and 6). This clear difference with the native isoforms strongly suggests that inhibitor treatment changes the pathway of intramolecular electron transfer in Compound I, resulting in oxidation of a surrogate tyrosine (exhibiting NS1a or NS2a EPR) rather than Tyr-385 (Tyr-371 in PGHS-2) during electron transfer to the heme porphyrin radical, as we previously proposed (18). The identity of this surrogate tyrosine residue is not known for either of the PGHS isoforms, although the similarity in power saturation between the NS1a and WD1 signals (12) and between the NS2a and WS2 signals (16) indicates similar environments for radicals on the surrogate tyrosine and on Tyr-385/Tyr-371.
The present kinetic data have revealed unexpected differences between
the two isozymes in the redox association between the heme center and
the tyrosyl radical (Figs. 2 and 4). Although formation of Intermediate
II heme paralleled formation of tyrosyl radicals in both isozymes, the
rate for PGHS-2 was faster than for PGHS-1. The faster rate of
Intermediate II/tyrosyl radical formation for PGHS-2 fits with our
recent comparative kinetic studies of these two isozymes, which showed
PGHS-2 to have a much faster conversion from Intermediate I to II (26).
Surprisingly, the redox relaxation of the tyrosyl radical and the heme
center parallel one another in PGHS-1 but diverge markedly in PGHS-2 (Figs. 2 and 4). A similar difference was observed with the NS radicals
in PGHS-1 and -2 treated with inhibitors (Figs. 3 and 6), with the
redox relaxation of the tyrosyl radical and the heme center paralleling
one another in PGHS-1 but diverging markedly in PGHS-2 (Fig. 2 and 4).
This uncoupling of the tyrosyl radical redox state from the heme redox
state in PGHS-2 may be physiologically significant because it tends to
prolong the lifetime of the catalytically active tyrosyl radical and
thus better sustain propagation of cyclooxygenase activity. This
difference in redox coupling between oxyferryl heme and the tyrosyl
radical in the two isoforms may contribute to the greater efficiency of
hydroperoxide activation in PGHS-2 than in PGHS-1 (21).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Guqiang Lu and Wei Chen for assistance in preparing the PGHS-2 enzyme.
| |
FOOTNOTES |
|---|
* This work was supported by United States Public Health Service Grants GM44911 (to A.-L. T.), GM52170 (to R. J. K.), and GM21337 (to G. P.) and by Welch Foundation Grant C636 (to G. P.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed: Div. of Hematology, University of Texas Health Science Center, P. O. Box 20708, Houston TX 77225. E-mail: atsai@heart.med.uth.tmc.edu.
2 W. Shi, C. W. Hoganson, M. Espe, C. J. Bender, G. T. Babcock, G. Palmer, R. J. Kulmacz, and A.-L. Tsai, submitted for publication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PGHS-1, ovine prostaglandin H synthase-1; EtOOH, ethyl hydrogen peroxide; WD, wide doublet tyrosyl radical; WS, wide singlet tyrosyl radical; NS, narrow singlet tyrosyl radical; EPR, electron paramagnetic resonance; ENDOR, electron nuclear double resonance.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Smith, W. L., and DeWitt, D. L. (1996) Adv. Immunol. 62, 167-215[Medline] [Order article via Infotrieve] |
| 2. | Herschman, H. R. (1996) Biochim. Biophys. Acta 1299, 125-140[Medline] [Order article via Infotrieve] |
| 3. | Picot, D., Loll, P. J., and Garavito, R. M. (1994) Nature 367, 243-249[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Luong, C., Miller, A., Barnett, J., Chow, J., Ramesha, C., and Browner, M. F. (1996) Nat. Struct. Biol. 3, 927-933[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Kurumbail, R. G., Stevens, A. M., Gierse, J. K., McDonald, J. J., Stegeman, R. A., Pak, J. Y., Gildehaus, D., Miyashiro, J. M., Penning, T. D., Seibert, K., Isakson, P. C., and Stallings, W. C. (1996) Nature 384, 644-648[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Lambeir, A. M.,
Markey, C. M.,
Dunford, H. B.,
and Marnett, L. J.
(1985)
J. Biol. Chem.
260,
14894-14896 |
| 7. | Karthein, R., Dietz, R., Nastainczyk, W., and Ruf, H. H. (1988) Eur. J. Biochem. 171, 313-320[Medline] [Order article via Infotrieve] |
| 8. | Dietz, R., Nastainczyk, W., and Ruf, H. H. (1988) Eur. J. Biochem. 171, 321-328[Medline] [Order article via Infotrieve] |
| 9. |
Tsai, A.,
Wei, C.,
Baek, H. K.,
Kulmacz, R. J.,
and Van Wart, H. E.
(1997)
J. Biol. Chem.
272,
8885-8894 |
| 10. |
Tsai, A.,
Kulmacz, R. J.,
and Palmer, G.
(1995)
J. Biol. Chem.
270,
10503-10508 |
| 11. |
Tsai, A.,
Palmer, G.,
Xiao, G.,
Swinney, D. C.,
and Kulmacz, R. J.
(1998)
J. Biol. Chem.
273,
3888-3894 |
| 12. | Kulmacz, R. J., Ren, Y., Tsai, A.-L., and Palmer, G. (1990) Biochemistry 29, 8760-8771[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Tsai, A.,
Palmer, G.,
and Kulmacz, R. J.
(1992)
J. Biol. Chem.
267,
17753-17759 |
| 14. |
Lassmann, G.,
Odenwaller, R.,
Curtis, J. F.,
DeGray, J. A.,
Mason, R. P.,
Marnett, L. J.,
and Eling, T. E.
(1991)
J. Biol. Chem.
266,
20045-20055 |
| 15. |
DeGray, J. A.,
Lassmann, G.,
Curtis, J. F.,
Kennedy, T. A.,
Marnett, L. J.,
Eling, T. E.,
and Mason, R. P.
(1992)
J. Biol. Chem.
267,
23583-23588 |
| 16. | Xiao, G., Tsai, A.-L., Palmer, G., Boyar, W. C., Marshall, P. J., and Kulmacz, R. J. (1997) Biochemistry 36, 1836-1845[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Kulmacz, R. J., Palmer, G., and Tsai, A-L. (1991) Mol. Pharmacol. 40, 833-837[Abstract] |
| 18. |
Tsai, A.,
Hsi, L. C.,
Kulmacz, R. J.,
Palmer, G.,
and Smith, W. L.
(1994)
J. Biol. Chem.
269,
5085-5091 |
| 19. | Tsai, A.-L., Berka, V., Kulmacz, R. J., Wu, G., and Palmer, G. (1998) Anal. Biochem. 264, 165-171[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Kulmacz, R. J., and Lands, W. E. M. (1987) in Prostaglandins and Related Substances: A Practical Approach (Benedetto, C. , McDonald-Gibson, R. G. , Nigam, S. , and Slater, T. F., eds) , pp. 209-227, IRL Press, Washington, D. C. |
| 21. |
Kulmacz, R. J.,
and Wang, L.-H.
(1995)
J. Biol. Chem.
270,
24019-24023 |
| 22. | Tsai, A.-L., Wu, G., and Kulmacz, R. J. (1997) Biochemistry 36, 13085-13094[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Stubbe, J., and van der Donk, W. A. (1998) Chem. Rev. 98, 705-762[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Hsi, L. C., Hoganson, C. W., Babcock, G. T., and Smith, W. L. (1994) Biochem. Biophys. Res. Commun. 202, 1592-1598[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Wu, G.,
Wei, C.,
Kulmacz, R. J.,
Osawa, Y.,
and Tsai, A.-L.
(1999)
J. Biol. Chem.
274,
9231-9237 |
| 26. |
Lu, G,
Tsai, A.-L.,
Van Wart, H. E.,
and Kulmacz, R. J.
(1999)
J. Biol. Chem.
274,
16162-16167 |
This article has been cited by other articles:
![]() |
Y. Y. Tyurina, V. Kini, V. A. Tyurin, I. I. Vlasova, J. Jiang, A. A. Kapralov, N. A. Belikova, J. C. Yalowich, I. V. Kurnikov, and V. E. Kagan Mechanisms of Cardiolipin Oxidation by Cytochrome c: Relevance to Pro- and Antiapoptotic Functions of Etoposide Mol. Pharmacol., August 1, 2006; 70(2): 706 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Spolitak, J. H. Dawson, and D. P. Ballou Reaction of Ferric Cytochrome P450cam with Peracids: KINETIC CHARACTERIZATION OF INTERMEDIATES ON THE REACTION PATHWAY J. Biol. Chem., May 27, 2005; 280(21): 20300 - 20309. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, S. Girotto, S. Yu, and R. S. Magliozzo Evidence for Radical Formation at Tyr-353 in Mycobacterium tuberculosis Catalase-Peroxidase (KatG) J. Biol. Chem., February 27, 2004; 279(9): 7606 - 7612. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bambai, C. E. Rogge, B. Stec, and R. J. Kulmacz Role of Asn-382 and Thr-383 in Activation and Inactivation of Human Prostaglandin H Synthase Cyclooxygenase Catalysis J. Biol. Chem., February 6, 2004; 279(6): 4084 - 4092. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Lardinois and P. R. O. de Montellano Intra- and Intermolecular Transfers of Protein Radicals in the Reactions of Sperm Whale Myoglobin with Hydrogen Peroxide J. Biol. Chem., September 19, 2003; 278(38): 36214 - 36226. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Du, H.-C. Yeh, V. Berka, L.-H. Wang, and A.-l. Tsai Redox Properties of Human Endothelial Nitric-oxide Synthase Oxygenase and Reductase Domains Purified from Yeast Expression System J. Biol. Chem., February 14, 2003; 278(8): 6002 - 6011. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chouchane, S. Girotto, S. Yu, and R. S. Magliozzo Identification and Characterization of Tyrosyl Radical Formation in Mycobacterium tuberculosis Catalase-Peroxidase (KatG) J. Biol. Chem., November 1, 2002; 277(45): 42633 - 42638. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Boutaud, D. M. Aronoff, J. H. Richardson, L. J. Marnett, and J. A. Oates Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases PNAS, May 14, 2002; 99(10): 7130 - 7135. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakamoto, H. Imai, and Y. Nakagawa Involvement of Phospholipid Hydroperoxide Glutathione Peroxidase in the Modulation of Prostaglandin D2 Synthesis J. Biol. Chem., December 15, 2000; 275(51): 40028 - 40035. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bambai and R. J. Kulmacz Prostaglandin H Synthase. EFFECTS OF PEROXIDASE COSUBSTRATES ON CYCLOOXYGENASE VELOCITY J. Biol. Chem., September 1, 2000; 275(36): 27608 - 27614. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Thuresson, M. G. Malkowski, K. M. Lakkides, C. J. Rieke, A. M. Mulichak, S. L. Ginell, R. M. Garavito, and W. L. Smith Mutational and X-ray Crystallographic Analysis of the Interaction of Dihomo-gamma -linolenic Acid with Prostaglandin Endoperoxide H Synthases J. Biol. Chem., March 23, 2001; 276(13): 10358 - 10365. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Lardinois and P. R. O. de Montellano H2O2-mediated Cross-linking between Lactoperoxidase and Myoglobin. ELUCIDATION OF PROTEIN-PROTEIN RADICAL TRANSFER REACTIONS J. Biol. Chem., June 15, 2001; 276(25): 23186 - 23191. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Malkowski, E. D. Thuresson, K. M. Lakkides, C. J. Rieke, R. Micielli, W. L. Smith, and R. M. Garavito Structure of Eicosapentaenoic and Linoleic Acids in the Cyclooxygenase Site of Prostaglandin Endoperoxide H Synthase-1 J. Biol. Chem., September 28, 2001; 276(40): 37547 - 37555. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||